SciSparc (SPRC) Accumulated Expenses (2016 - 2025)
SciSparc (SPRC) posted Accumulated Expenses of $495000.0 for Q4 2025, down 18.59% sequentially from $608000.0 in Q4 2024, and down 18.59% YoY from $608000.0 in Q4 2024.
SciSparc (SPRC) Accumulated Expenses (2016 - 2025) Analysis & Trends
SciSparc has reported Accumulated Expenses for 10 years, with the latest figure at $495000.0 in Q4 2025.
- Quarterly Accumulated Expenses fell 18.59% year-over-year to $495000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $495000.0 (down 18.59% YoY) and the FY2025 annual result came in at $495000.0, down 18.59% from the prior year.
- Accumulated Expenses declined to $495000.0 in Q4 2025 per SPRC's latest filing, from $608000.0 in the prior quarter.
- Over five years, Accumulated Expenses peaked at $901000.0 in Q4 2022 and troughed at $495000.0 in Q4 2025.
- A 5-year average of $660000.0 and a median of $608000.0 in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2021 and 2023: Accumulated Expenses surged 171.68% in 2021, then slumped 40.29% in 2023.
- Over 5 years, Accumulated Expenses stood at $758000.0 in 2021, then climbed by 18.87% to $901000.0 in 2022, then plunged by 40.29% to $538000.0 in 2023, then advanced by 13.01% to $608000.0 in 2024, then decreased by 18.59% to $495000.0 in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $495000.0, $608000.0, and $538000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 495,000.00 |
| Dec 31, 2024 | 608,000.00 |
| Dec 31, 2023 | 538,000.00 |
| Dec 31, 2022 | 901,000.00 |
| Dec 31, 2021 | 758,000.00 |
| Dec 31, 2020 | 279,000.00 |
| Dec 31, 2019 | 525,000.00 |
| Dec 31, 2018 | 640,000.00 |
| Dec 31, 2017 | 618,000.00 |
| Dec 31, 2016 | 510,000.00 |